	Balance Sheet March 31, 2018
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	7,033		$	-			$	7,033
Accounts receivable, trade, net of allowance for doubtful accounts of $6 at March 31, 2018		1,043			-				1,043
Inventories		1,837			-				1,837
Prepaid expenses and other current assets		331			-				331
Total current assets		10,244			-				10,244

Property and equipment, net					-
Leasehold improvements		1,284			-				1,284
Furniture and computer equipment		692			-				692
Manufacturing and other equipment		1,195			-				1,195
Subtotal		3,171			-				3,171
Less: Accumulated depreciation		(2,084	)		-				(2,084	)
Net property and equipment		1,087			-				1,087
Investment in SAVSU		926			-				926
Long-term deposits		36			-				36
Total assets	$	12,293		$	-			$	12,293

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		586			-				586
Accrued expenses and other current liabilities		204			-				204
Accrued compensation		392			-				392
Deferred rent, current portion		130			-
Total current liabilities		1,312			-				1,312
Deferred rent, long-term		457			-				457
Warrant liability		-			14,725		(a)		14,725
Other long-term liabilities		52			-				52
Total liabilities		1,821			14,725				16,546

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at March 31, 2018		-			-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 14,145,413 shares issued and outstanding at March 31, 2018		14			-				14
Additional paid-in capital		84,518			(20,501	)	(a)		64,017
Accumulated deficit		(74,060	)		5,776		(a)		(68,284	)
Total shareholders’ equity (deficit)		10,472			(14,725	)			(4,253	)
Total liabilities and shareholders’ equity	$	12,293		$	-			$	12,293

	Balance Sheet June 30, 2018
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	14,167		$	-			$	14,167
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at June 30, 2018		2,166			-				2,166
Inventories		2,122			-				2,122
Prepaid expenses and other current assets		352			-				352
Total current assets		18,807			-				18,807

Property and equipment, net					-
Leasehold improvements		1,284			-				1,284
Furniture and computer equipment		693			-				693
Manufacturing and other equipment		1,230			-				1,230
Subtotal		3,207			-				3,207
Less: Accumulated depreciation		(2,163	)		-				(2,163	)
Net property and equipment		1,044			-				1,044
Investment in SAVSU		1,900			-				1,900
Long-term deposits		36			-				36
Total assets	$	21,787		$	-			$	21,787

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		843			-				843
Accrued expenses and other current liabilities		173			-				173
Accrued compensation		518			-				518
Deferred rent, current portion		130			-
Total current liabilities		1,664			-				1,664
Deferred rent, long-term		423			-				423
Warrant liability		-			32,599		(a)		32,599
Other long-term liabilities		45			-				45
Total liabilities		2,132			32,599				34,731

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at June 30, 2018		-			-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 16,107,505 shares issued and outstanding at June 30, 2018		16			-				16
Additional paid-in capital		92,654			(10,892	)	(a)		81,762
Accumulated deficit		(73,015	)		(21,707	)	(a)		(94,722	)
Total shareholders’ equity (deficit)		19,655			(32,599	)			(12,944	)
Total liabilities and shareholders’ equity	$	21,787		$	-			$	21,787

	Balance Sheet September 30, 2018
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	32,381		$	-			$	32,381
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at September 30, 2018		2,699			-				2,699
Inventories		2,911			-				2,911
Prepaid expenses and other current assets		298			-				298
Total current assets		38,289			-				38,289

Property and equipment, net					-
Leasehold improvements		1,284			-				1,284
Furniture and computer equipment		706			-				706
Manufacturing and other equipment		1,511			-				1,511
Subtotal		3,501			-				3,501
Less: Accumulated depreciation		(2,234	)		-				(2,234	)
Net property and equipment		1,267			-				1,267
Investment in SAVSU		6,857			-				6,857
Long-term deposits		36			-				36
Total assets	$	46,449		$	-			$	46,449

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		1,090			-				1,090
Accrued expenses and other current liabilities		162			-				162
Accrued compensation		713			-				713
Deferred rent, current portion		130			-
Total current liabilities		2,095			-				2,095
Deferred rent, long-term		386			-				386
Warrant liability		-			50,425		(a)		50,425
Other long-term liabilities		38			-				38
Total liabilities		2,519			50,425				52,944

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 shares issued and outstanding at September 30, 2018		-			-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,237,425 shares issued and outstanding at September 30, 2018		18			-				18
Additional paid-in capital		115,776			(3,021	)	(a)		112,755
Accumulated deficit		(71,864	)		(47,404	)	(a)		(119,268	)
Total shareholders’ equity (deficit)		43,930			(50,425	)			(6,495	)
Total liabilities and shareholders’ equity	$	46,449		$	-			$	46,449

	Balance Sheet March 31, 2019
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	31,824		$	-			$	31,824
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at March 31, 2019		2,927			-				2,927
Inventories		4,060			-				4,060
Prepaid expenses and other current assets		346			-				346
Total current assets		39,157			-				39,157

Property and equipment, net
Leasehold improvements		1,284			-				1,284
Furniture and computer equipment		704			-				704
Manufacturing and other equipment		1,803			-				1,803
Subtotal		3,791			-				3,791
Less: Accumulated depreciation		(2,424	)		-				(2,424	)
Net property and equipment		1,367			-				1,367
Operating lease right-of-use assets		1,196			-				1,196
Investment in SAVSU		6,317			-				6,317
Long-term deposits		36			-				36
Total assets	$	48,073		$	-			$	48,073

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		1,264			-				1,264
Accrued expenses and other current liabilities		142			-				142
Accrued compensation		630			-				630
Lease liability - operating, current position		651			-				651
Lease liability - financing, current position		14			-				14
Total current liabilities		2,701			-				2,701
Long-term lease liability - operating		980			-				980
Long-term lease liability - financing		13			-				13
Warrant liability		-			48,106		(a)		48,106
Other long-term liabilities		13			-				13
Total liabilities		3,707			48,106				51,813

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at March 31, 2019		-			-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,717,095 shares issued and outstanding at March 31, 2019		19			-				19
Additional paid-in capital		114,951			(1,154	)	(a)		113,797
Accumulated deficit		(70,604	)		(46,952	)	(a)		(117,556	)
Total shareholders’ equity (deficit)		44,366			(48,106	)			(3,740	)
Total liabilities and shareholders’ equity	$	48,073		$	-			$	48,073

	Balance Sheet June 30, 2019
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	19,617		$	-			$	19,617
Accounts receivable, trade, net of allowance for doubtful accounts of $26 at June 30, 2019		3,832			-				3,832
Inventories		5,306			-				5,306
Prepaid expenses and other current assets		384			-				384
Total current assets		29,139			-				29,139

Property and equipment, net
Leasehold improvements		1,284			-				1,284
Furniture and computer equipment		577			-				577
Manufacturing and other equipment		1,733			-				1,733
Subtotal		3,594			-				3,594
Less: Accumulated depreciation		(2,276	)		-				(2,276	)
Net property and equipment		1,318			-				1,318
Operating lease right-of-use assets		1,079			-				1,079
Investment in SAVSU		6,100			-				6,100
Intangible assets, net		4,446			(430	)	(c)		4,016
Goodwill		9,524			(9	)	(b),(c)		9,515
Long-term deposits		136			-				136
Total assets	$	51,742		$	(439	)		$	51,303

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		876			-				876
Accrued expenses and other current liabilities		204			-				204
Accrued compensation		963			-				963
Lease liability - operating, current position		665			-				665
Lease liability - financing, current position		14			-				14
Contingent consideration - current		371			70		(b)		441
Total current liabilities		3,093			70				3,163
Long-term lease liability - operating		806			-				806
Long-term lease liability - financing		10			-				10
Warrant liability		-			44,194		(a)		44,194
Other long-term liabilities		7			-				7
Contingent consideration - long-term		1,560			(509	)	(b)		1,051
Total liabilities		5,476			43,755				49,231

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at June 30, 2019		-			-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 18,898,609 shares issued and outstanding at June 30, 2019		19			-				19
Additional paid-in capital		116,013			(656	)	(a)		115,357
Accumulated deficit		(69,766	)		(43,538	)	(a),(d)		(113,304	)
Total shareholders’ equity (deficit)		46,266			(44,194	)			2,072
Total liabilities and shareholders’ equity	$	51,742		$	(439	)		$	51,303

	Balance Sheet September 30, 2019
(In thousands, except share and per share data)	As Previously Reported			Adjustments				As Restated
Assets
Current assets
Cash and cash equivalents	$	21,205		$	-			$	21,205
Accounts receivable, trade, net of allowance for doubtful accounts of $68 at September 30, 2019		4,313			-				4,313
Inventories		5,694			-				5,694
Prepaid expenses and other current assets		855			-				855
Total current assets		32,067			-				32,067

Property and equipment, net					-
Leasehold improvements		1,599			-				1,599
Furniture and computer equipment		588			-				588
Manufacturing and other equipment		2,247			-				2,247
Subtotal		4,434			-				4,434
Less: Accumulated depreciation		(2,298	)		-				(2,298	)
Net property and equipment		2,136			-				2,136
Assets held for rent, net		2,976							2,976
Operating lease right-of-use assets		1,177			-				1,177
Investment in SAVSU		1,000			-				1,000
Intangible assets, net		16,485			(430	)	(c)		16,055
Goodwill		28,351			(9	)	(b),(c)		28,342
Long-term deposits		36			-				36
Total assets	$	84,228		$	(439	)		$	83,789

Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		1,570			-				1,570
Accrued expenses and other current liabilities		642			-				642
Accrued compensation		1,576			-				1,576
Lease liability - operating, current position		771			-				771
Lease liability - financing, current position		14			-				14
Contingent consideration - current		371			70		(b)		441
Total current liabilities		4,944			70				5,014
Long-term lease liability - operating		753			-				753
Long-term lease liability - financing		6			-				6
Warrant liability		-			41,771		(a)		41,771
Other long-term liabilities		3			-				3
Contingent consideration - long-term		1,560			(509	)	(b)		1,051
Total liabilities		7,266			41,332				48,598

Commitments and Contingencies

Shareholders’ equity (deficit)
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at September 30, 2019					-				-
Common stock, $0.001 par value; 150,000,000 shares authorized, 20,344,825 shares issued and outstanding at June 30, 2019		20			-				20
Additional paid-in capital		137,392			814		(a)		138,206
Accumulated deficit		(60,450	)		(42,585	)	(a),(d)		(103,035	)
Total shareholders’ equity (deficit)		76,962			(41,771	)			35,191
Total liabilities and shareholders’ equity	$	84,228		$	(439	)		$	83,789

(In thousands, except per share and share data )	Statement of Operations Three Months Ending March 31, 2018
	As Previously Reported			Adjustments				As Restated
Revenue	$	3,815		$	-			$	3,815

Operating expenses
Cost of revenue		1,364			-				1,364
Research and development		346			-				346
Sales and marketing		612			-				612
General and administrative		1,353			-				1,353
Total operating expenses		3,675			-				3,675
Operating income (loss)		140			-				140

Other income (expenses)
Change in fair value of warrant liability		-			4,870		(a)		4,870
Interest income		8			-				8
Interest expense		(1	)		-				(1	)
Loss from equity-method investment in SAVSU		(144	)		-				(144	)
Total other income (expenses)		(137	)		4,870				4,733

Net income (loss)		3			4,870				4,873
Less: Preferred stock dividends		(106	)		-				(106	)
Net income (loss) attributable to common stockholders	$	(103	)	$	4,870			$	4,767


Net income (loss) attributable to common stockholders:
Basic	$	(103	)	$	3,250			$	3,147
Diluted	$	(103	)	$	(179	)		$	(282	)
Earnings per share attributable to common stockholders:
Basic	$	(0.01	)	$	0.23			$	0.22
Diluted	$	(0.01	)	$	(0.01	)		$	(0.02	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		14,098,610			-				14,098,610
Diluted		14,098,610			-				14,098,610

(In thousands, except per share and share data)	Statement of Operations Three Months Ending June 30, 2018										Statement of Operations Six Months Ending June 30, 2018
	As Previously Reported			Adjustments				As Restated			As Previously Reported			Adjustments				As Restated
Revenue	$	5,178		$	-			$	5,178		$	8,993		$	-			$	8,993

Operating expenses
Cost of revenue		1,537			-				1,537			2,901			-				2,901
Research and development		325			-				325			671			-				671
Sales and marketing		641			-				641			1,253			-				1,253
General and administrative		1,390			-				1,390			2,744			-				2,744
Total operating expenses		3,893			-				3,893			7,569			-				7,569
Operating income (loss)		1,285			-				1,285			1,424			-				1,424

Other income (expenses)
Change in fair value of warrant liability		-			(27,485	)	(a)		(27,485	)		-			(22,615	)	(a)		(22,615	)
Interest income		32			-				32			41			-				41
Interest expense		(1	)		-				(1	)		(1	)		-				(1	)
Loss from equity-method investment in SAVSU		(177	)		-				(177	)		(321	)		-				(321	)
Total other income (expenses)		(146	)		(27,485	)			(27,631	)		(281	)		(22,615	)			(22,896	)

Net income (loss)		1,139			(27,485	)			(26,346	)		1,143			(22,615	)			(21,472	)
Less: Preferred stock dividends		(93	)		-				(93	)		(200	)		-				(200	)
Net income (loss) attributable to common stockholders		1,046			(27,485	)			(26,439	)		943			(22,615	)			(21,672	)


Net income (loss) attributable to common stockholders:
Basic	$	1,046		$	(27,485	)		$	(26,439	)	$	943		$	(22,614	)		$	(21,672	)
Diluted	$	1,046		$	(27,485	)		$	(26,439	)	$	943		$	(22,614	)		$	(21,672	)
Earnings per share attributable to common stockholders:
Basic	$	0.07		$	(1.81	)		$	(1.74	)	$	0.06		$	(1.54	)		$	(1.48	)
Diluted	$	0.05		$	(1.79	)		$	(1.74	)	$	0.05		$	(1.53	)		$	(1.48	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		15,180,169			-				15,180,169			14,642,378			-				14,642,378
Diluted		20,374,358			(5,194,189	)			15,180,169			19,063,595			(4,421,217	)			14,642,378

(In thousands, except per share and share data)	Statement of Operations Three Months Ending September 30, 2018										Statement of Operations Nine Months Ending September 30, 2018
	As Previously Reported			Adjustments				As Restated			As Previously Reported			Adjustments				As Restated
Revenue	$	5,293		$	-			$	5,293		$	14,286		$	-			$	14,286

Operating expenses
Cost of revenue		1,606			-				1,606			4,507			-				4,507
Research and development		312			-				312			983			-				983
Sales and marketing		725			-				725			1,978			-				1,978
General and administrative		1,455			-				1,455			4,199			-				4,199
Total operating expenses		4,098			-				4,098			11,667			-				11,667
Operating income (loss)		1,195			-				1,195			2,619			-				2,619

Other income (expenses)
Change in fair value of warrant liability		-			(25,696	)	(a)		(25,696	)		-			(48,311	)	(a)		(48,311	)
Interest income		80			-				80			121			-				121
Interest expense		(1	)		-				(1	)		(4	)		-				(4	)
Loss from equity-method investment in SAVSU		(43	)		-				(43	)		(363	)		-				(363	)
Total other income (expenses)		36			(25,696	)			(25,660	)		(246	)		(48,311	)			(48,557	)

Net income (loss)		1,231			(25,696	)			(24,465	)		2,373			(48,311	)			(45,938	)
Less: Preferred stock dividends		(80	)		-				(80	)		(279	)		-				(279	)
Net income (loss) attributable to common stockholders		1,151			(25,696	)			(24,545	)		2,094			(48,311	)			(46,217	)


Net income (loss) attributable to common stockholders:
Basic	$	1,151		$	(25,696	)		$	(24,545	)	$	2,094		$	(48,311	)		$	(46,217	)
Diluted	$	1,151		$	(25,696	)		$	(24,545	)	$	2,094		$	(48,311	)		$	(46,217	)
Earnings per share attributable to common stockholders:
Basic	$	0.07		$	(1.49	)		$	(1.42	)	$	0.13		$	(3.11	)		$	(2.98	)
Diluted	$	0.05		$	(1.47	)		$	(1.42	)	$	0.10		$	(3.08	)		$	(2.98	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		17,273,412			-				17,273,412			15,529,026			-				15,529,026
Diluted		23,656,633			(6,383,221	)			17,273,412			21,051,219			(5,522,193	)			15,529,026

(In thousands, except per share and share data)	Statement of Operations Three Months Ending March 31, 2019
	As Previously Reported			Adjustments				As Restated
Revenue	$	5,770		$	-			$	5,770

Operating expenses
Cost of revenue		1,647			-		(e)		1,647
Research and development		372			(13	)	(d),(e)		359
Sales and marketing		848			(11	)	(d),(e)		837
General and administrative		2,204			(51	)	(d)		2,153
Acquisition Costs		208			-				208
Total operating expenses		5,279			(75	)			5,204
Operating income (loss)		491			75				566

Other income (expenses)
Change in fair value of warrant liability		-			(19,663	)	(a)		(19,663	)
Interest income		171			-				171
Interest expense		(3	)		-				(3	)
Loss from equity-method investment in SAVSU		(232	)		-				(232	)
Total other income (expenses)		(64	)		(19,663	)			(19,727	)

Income (loss) before provision for income taxes		427			(19,588	)			(19,161	)
Income taxes		-			-				-
Net income (loss)		427			(19,588	)			(19,161	)

Net income (loss) attributable to common stockholders:
Basic	$	427		$	(19,588	)		$	(19,161	)
Diluted	$	427		$	(19,588	)		$	(19,161	)
Earnings per share attributable to common stockholders:
Basic	$	0.02		$	(1.05	)		$	(1.03	)
Diluted	$	0.02		$	(1.05	)		$	(1.03	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		18,648,397			-				18,648,397
Diluted		24,358,475			(5,710,078	)			18,648,397

(In thousands, except per share and share data)	Statement of Operation Three Months Ending June 30, 2019										Statement of Operations Six Months Ending June 30, 2019
	As Previously Reported			Adjustments				As Restated			As Previously Reported			Adjustments				As Restated
Revenue	$	6,701		$	-			$	6,701		$	12,471		$	-			$	12,471

Operating expenses
Cost of product revenue (exclusive of intangible assets amortization)		1,958			10		(d),(e)		1,968			3,606			10		(d),(e)		3,616
Research and development		739			(48	)	(d),(e)		691			1,111			(61	)	(d),(e)		1,050
Sales and marketing		928			17		(d),(e)		945			1,776			6		(d),(e)		1,782
General and administrative		2,118			89		(d)		2,207			4,321			38		(d)		4,359
Amort of Intangibles		-			104		(e)		104			-			104		(e)		104
Acquisition Costs		39			-				39			247			-				247
Total operating expenses		5,782			172				5,954			11,061			97				11,158
Operating income (loss)		919			(172	)			747			1,410			(97	)			1,313

Other income (expenses)
Change in fair value of warrant liability		-			3,586		(a)		3,586			-			(16,077	)	(a)		(16,077	)
Interest income		137			-				137			307			-				307
Interest expense		(1	)		-				(1	)		(4	)		-				(4	)
Other Expense		-			-				-			-			-				-
Loss from equity-method investment in SAVSU		(217	)		-				(217	)		(448	)		-				(448	)
Gain on Acquisition of SAVSU		-			-				-			-			-				-
Total other income (expenses)		(81	)		3,586				3,505			(145	)		(16,077	)			(16,222	)

Income (loss) before provision for income taxes		838			3,414				4,252			1,265			(16,174	)			(14,909	)
Income taxes		-			-				-			-			-				-
Net income (loss)		838			3,414				4,252			1,265			(16,174	)			(14,909	)


Net income (loss) attributable to common stockholders:
Basic	$	838		$	2,587			$	3,425		$	1,265		$	(16,174	)		$	(14,909	)
Diluted	$	838		$	(293	)		$	545		$	1,265		$	(16,174	)		$	(14,909	)
Earnings per share attributable to common stockholders:
Basic	$	0.04		$	0.14			$	0.18		$	0.07		$	(0.87	)		$	(0.80	)
Diluted	$	0.03		$	(0.01	)		$	0.02		$	0.05		$	(0.85	)		$	(0.80	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		18,819,459			-				18,819,459			18,734,401			-				18,734,401
Diluted		24,539,299			-				24,539,299			24,439,959			(5,705,558	)			18,734,401

(In thousands, except per share and share data)	Statement of Operations Three Months Ending September 30, 2019										Statement of Operations Nine Months Ending September 30, 2019
	As Previously Reported			Adjustments				As Restated			As Previously Reported			Adjustments				As Restated
Revenue	$	6,604		$	-			$	6,604		$	19,075		$	-			$	19,075

Operating expenses
Cost of product and rental revenue (exclusive of intangible assets amortization)		2,084			10		(d),(e)		2,094			5,690			20		(d),(e)		5,710
Research and development		1,309			(277	)	(d),(e)		1,032			2,420			(338	)	(d),(e)		2,082
Sales and marketing		1,259			(9	)	(d),(e)		1,250			3,035			(3	)	(d),(e)		3,032
General and administrative		2,258			90		(d)		2,348			6,579			128		(d)		6,707
Amort of Intangibles		-			361		(e)		361			-			465		(e)		465
Acquisition Costs		291			-				291			538			-				538
Total operating expenses		7,201			175				7,376			18,262			272				18,534
Operating income (loss)		(597	)		(175	)			(772	)		813			(272	)			541

Other income (expenses)
Change in fair value of warrant liability		-			1,128		(a)		1,128			-			(14,949	)	(a)		(14,949	)
Interest income		110			-				110			417			-				417
Interest expense		(1	)		-				(1	)		(5	)		-				(5	)
Other Expense		(13	)		-				(13	)		(13	)		-				(13	)
Loss from equity-method investment in SAVSU		(291	)		-				(291	)		(739	)		-				(739	)
Gain on Acquisition of SAVSU		10,108			-				10,108			10,108			-				10,108
Total other income (expenses)		9,913			1,128				11,041			9,768			(14,949	)			(5,181	)

Income (loss) before provision for income taxes		9,316			953				10,269			10,581			(15,221	)			(4,640	)
Income taxes		-			-				-			-			-				-
Net income (loss)		9,316			953				10,269			10,581			(15,221	)			(4,640	)


Net income (loss) attributable to common stockholders:
Basic	$	9,316		$	(936	)		$	8,380		$	10,581		$	(15,221	)		$	(4,640	)
Diluted		9,316			(454	)			8,862			10,581			(15,221	)			(4,640	)
Earnings per share attributable to common stockholders:
Basic	$	0.47		$	(0.05	)		$	0.42		$	0.55		$	(0.79	)		$	(0.24	)
Diluted	$	0.37		$	(0.02	)		$	0.35		$	0.43		$	(0.67	)		$	(0.24	)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic		19,735,364			-				19,735,364			19,071,722			-				19,071,722
Diluted		25,343,112			-				25,343,112			24,705,424			(5,633,702	)			19,071,722

	Three Months Ended March 30, 2018
(In thousands)	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income	$	3		$	4,870		(a)	$	4,873
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation		78			-				78
Stock-based compensation		373			-				373
Amortization of deferred rent related to lease incentives		(32	)		-				(32	)
Amortization of debt discount		-			-				-
Loss from equity method investment in SAVSU		144			-				144
Change in fair value of warrant liability		-			(4,870	)	(a)		(4,870	)

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		(23	)		-				(23	)
Inventories		10			-				10
Prepaid expenses and other current assets		12			-				12
(Increase) Decrease in
Accounts payable		(69	)		-				(69	)
Accrued compensation and other current liabilities		(101	)		-				(101	)
Deferred rent		(3	)		-				(3	)
Net cash provided by operating activities		392			-				392

Cash flows from investing activities
Purchase of property and equipment		(41	)		-				(41	)
Net cash used in investing activities		(41	)		-				(41	)

Cash flows from financing activities
Payments on equipment loan		(2	)		-				(2	)
Payments on capital lease obligation		(3	)		-				(3	)
Proceeds from exercise of common stock options and warrants		130			-				130
Payments of preferred stock dividends		(106	)		-				(106	)
Net cash provided by financing activities		19			-				19

Net increase (decrease) in cash and cash equivalents		370			-				370
									-
Cash and cash equivalents – beginning of period		6,663			-				6,663
Cash and cash equivalents – end of year	$	7,033		$	-			$	7,033
Non-cash investing and financing activities
Stock issued for services provided in prior period included in liabilities at year-end	$	36		$	-			$	36
Purchase of equipment with debt		18			-				18
Series A preferred stock dividends accrued not yet paid		106			-				106
Reclassification of warrant liabilities to equity upon exercise	$	-		$	29			$	29

	Six Months Ended June 30, 2018
(In thousands )	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income (loss)	$	1,143		$	(22,615	)	(a)	$	(21,472	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation		161			-				161
Stock-based compensation		748			-				748
Stock issued for services
Amortization of deferred rent related to lease incentives		(63	)		-				(63	)
Loss from equity method investment in SAVSU		321			-				321
Change in fair value of warrant liability		-			22,615		(a)		22,615

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		(1,145	)		-				(1,145	)
Inventories		(275	)		-				(275	)
Prepaid expenses and other current assets		(103	)		-				(103	)
Accounts payable		168			-				168
Accrued compensation and other current liabilities		6			-				6
Deferred rent		(6	)		-				(6	)
Net cash provided by operating activities		955			-				955

Cash flows from investing activities
Investment in equity investment SAVSU		(1,000	)		-				(1,000	)
Purchase of property and equipment		(61	)		-				(61	)
Net cash used in investing activities		(1,061	)		-				(1,061	)

Cash flows from financing activities
Payments on equipment loan		(5	)		-				(5	)
Payments on capital lease obligation		(7	)		-				(7	)
Proceeds from exercise of common stock options and warrants		8,899			-				8,899
Payments of preferred stock dividends		(213	)		-				(213	)
Payments for redemption of preferred stock		(1,063	)		-				(1,063	)
Net cash provided by financing activities		7,611			-				7,611

Net increase (decrease) in cash and cash equivalents		7,505			-				7,505
									-
Cash and cash equivalents – beginning of period		6,663			-				6,663
Cash and cash equivalents – end of year	$	14,168		$	-			$	14,168
Non-cash investing and financing activities
Series A preferred stock dividends accrued not yet paid	$	93		$	-			$	93
Stock issued for services provided in prior period included in liabilities at year-end		36			-				36
Receivables converted to equity investment in SAVSU		150			-				150
Purchase of equipment with debt		18			-				18
Purchase of property and equipment not yet paid		20			-				20
Reclassification of warrant liabilities to equity upon exercise	$	-		$	9,639			$	9,639

	Nine Months Ended September 30, 2018
(In thousands)	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income (loss)	$	2,373		$	(48,311	)	(a)	$	(45,938	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation		245			-				245
Stock-based compensation		1,131			-				1,131
Stock issued for services
Write off of deferred financing costs
Amortization of deferred rent related to lease incentives		(95	)		-				(95	)
Loss from equity method investment in SAVSU		363			-				363
Change in fair value of warrant liability		-			48,311		(a)		48,311

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		(1,678	)		-				(1,678	)
Inventories		(1,064	)		-				(1,064	)
Prepaid expenses and other current assets		(49	)		-				(49	)
Accounts payable		343			-				343
Accrued compensation and other current liabilities		205			-				205
Deferred rent		(11	)		-				(11	)
Net cash provided by operating activities		1,763			-				1,763

Cash flows from investing activities
Investment in equity investment SAVSU		(6,000	)		-				(6,000	)
Purchase of property and equipment		(339	)		-				(339	)
Net cash used in investing activities		(6,339	)		-				(6,339	)

Cash flows from financing activities
Proceeds from private equity transaction		20,000			-				20,000
Payments on equipment loan		(9	)		-				(9	)
Payments on capital lease obligation		(10	)		-				(10	)
Proceeds from exercise of common stock options and warrants		11,725			-				11,725
Payments of preferred stock dividends		(306	)		-				(306	)
Payments for redemption of preferred stock		(1,063	)		-				(1,063	)
Deferred costs related to security issuance		(43	)		-				(43	)
Net cash provided by financing activities		30,294			-				30,294

Net increase (decrease) in cash and cash equivalents		25,718			-				25,718
									-
Cash and cash equivalents – beginning of period		6,663			-				6,663
Cash and cash equivalents – end of year	$	32,381		$	-			$	32,381
Non-cash investing and financing activities
Series A preferred stock dividends accrued not yet paid	$	80		$	-			$	80
Stock issued for services provided in prior period included in liabilities at year-end		36			-				36
Receivables converted to equity investment in SAVSU		150			-				150
Purchase of equipment with debt		18			-				18
Legal fees for private equity transaction not yet paid		43			-				43
Purchase of property and equipment not yet paid		49			-				49
Reclassification of warrant liabilities to equity upon exercise	$	-		$	17,509			$	17,509

	Three Months Ended March 30, 2019
(In thousands)	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income (loss)	$	427		$	(19,588	)	(a)	$	(19,161	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation		98			-				98
Stock-based compensation		606			(75	)	(d)		531
Amortization of operating lease liability		(43	)		-				(43	)
Interest expense - finance type lease		2			-				2
Loss from equity method investment in SAVSU		232			-				232
Change in fair value of warrant liability		-			19,663		(a)		19,663

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		118			-				118
Inventories		(551	)		-				(551	)
Prepaid expenses and other current assets		6			-				6
(Increase) Decrease in
Accounts payable		553			-				553
Accrued compensation and other current liabilities		(302	)		-				(302	)
Net cash provided by operating activities		1,146			-				1,146

Cash flows from investing activities
Purchase of property and equipment		(156	)		-				(156	)
Net cash used in investing activities		(156	)		-				(156	)

Cash flows from financing activities
Payments on equipment loan		(4	)		-				(4	)
Payments on capital lease obligation		(4	)		-				(4	)
Proceeds from exercise of common stock options and warrants		185			-				185
Net cash provided by financing activities		177			-				177

Net increase (decrease) in cash and cash equivalents		1,167			-				1,167

Cash and cash equivalents – beginning of period		30,657			-				30,657
Cash and cash equivalents – end of year	$	31,824		$	-			$	31,824
Non-cash investing and financing activities
Stock issued for services provided in prior period included in liabilities at year-end	$	-		$	-			$	-
Purchase of equipment with debt		-			-				-
Series A preferred stock dividends accrued not yet paid		-			-				-
Purchase of property and equipment not yet paid		46			-				46
Reclassification of warrant liabilities to equity upon exercise	$	-		$	73			$	73

	Six Months Ended June 30, 2019
(In thousands)	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income (loss)	$	1,265		$	(16,174	)	(a)	$	(14,909	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation		209			-				209
Stock-based compensation		1,252			97		(d)		1,349
Amortization of deferred rent related to lease incentives		-			-				-
Amortization of operating lease liability		(87	)		-				(87	)
Interest expense - finance type lease		2			-				2
Loss from equity method investment in SAVSU		448			-				448
Amortization of intangible assets		104			-				104
Change in fair value of warrant liability		-			16,077		(a)		16,077

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		(632	)		-				(632	)
Inventories		(1,341	)		-				(1,341	)
Prepaid expenses and other current assets		(32	)		-				(32	)
(Increase) Decrease in									-
Accounts payable		(36	)		-				(36	)
Accrued compensation and other current liabilities		(20	)		-				(20	)
Deferred rent		-			-				-
Other liabilities		(53	)		-				(53	)
Net cash provided by operating activities		1,079			-				1,079

Cash flows from investing activities
Payments related to the Astero Bio Acquisition, net of cash acquired		(12,438	)		-				(12,438	)
Investment in equity investment SAVSU		-			-				-
Purchase of property and equipment		(267	)		-				(267	)
Net cash used in investing activities		(12,705	)		-				(12,705	)

Cash flows from financing activities
Payments on equipment loan		(8	)		-				(8	)
Payments on capital lease obligation		(7	)		-				(7	)
Proceeds from exercise of common stock options and warrants		600			-				600
Net cash provided by financing activities		585			-				585

Net increase (decrease) in cash and cash equivalents		(11,041	)		-				(11,041	)

Cash and cash equivalents – beginning of period		30,657			-				30,657
Cash and cash equivalents – end of year	$	19,616		$	-			$	19,616
Non-cash investing and financing activities
Series A preferred stock dividends accrued not yet paid	$	-		$	-			$	-
Stock issued for services provided in prior period included in liabilities at year-end		-			-				-
Receivables converted to equity investment in SAVSU		-			-				-
Purchase of equipment with debt		-			-				-
Purchase of property and equipment not yet paid		4			-				4
Reclassification of warrant liabilities to equity upon exercise	$	-		$	400			$	400

	Nine Months Ended September 30, 2019
(In thousands)	As Previously Reported			Adjustments				Restated
Cash flows from operating activities
Net income (loss)	$	10,581		$	(15,221	)	(a)	$	(4,640	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation		373			-				373
Loss on disposal of property and equipment		13			-				13
Stock-based compensation		1,907			272		(d)		2,179
Amortization of operating lease liability		(132	)		-				(132	)
Interest expense - finance type lease		2			-				2
Loss from equity method investment in SAVSU		739			-				739
Gain on acquisition of SAVSU		(10,108	)		-				(10,108	)
Amortization of intangible assets		465			-				465
Change in fair value of warrant liability		-			14,949		(a)		14,949

Change in operating assets and liabilities
(Increase) Decrease in
Accounts receivable, trade, net		(372	)		-				(372	)
Inventories		(1,730	)		-				(1,730	)
Prepaid expenses and other current assets		(272	)		-				(272	)
Other assets, net		(87	)		-				(87	)
(Increase) Decrease in
Accounts payable		377			-				377
Accrued compensation and other current liabilities		558			-				558
Other liabilities		(98	)		-				(98	)
Net cash provided by operating activities		2,216			-				2,216

Cash flows from investing activities
Cash acquired on acquisition of SAVSU		1,251			-				1,251
Payments related to the Astero Bio Acquisition, net of cash acquired		(12,439	)		-				(12,439	)
Investment in iVexSol		(1,000	)		-				(1,000	)
Purchase of property and equipment		(356	)		-				(356	)
Purchase of assets held for rent		(453	)		-				(453	)
Net cash used in investing activities		(12,997	)		-				(12,997	)

Cash flows from financing activities
Proceeds from private equity transaction					-				-
Payments of costs related to Stock Issuances		(44	)		-				(44	)
Payments on equipment loan		(12	)		-				(12	)
Payments on finance lease obligation		(9	)		-				(9	)
Proceeds from exercise of common stock options and warrants		1,394			-				1,394
Net cash provided by financing activities		1,329			-				1,329

Net increase (decrease) in cash and cash equivalents		(9,452	)		-				(9,452	)
									-
Cash and cash equivalents – beginning of period		30,657			-				30,657
Cash and cash equivalents – end of year	$	21,205		$	-			$	21,205
Non-cash investing and financing activities
Purchase of equipment with debt	$	146		$	-			$	146
Purchase of property and equipment not yet paid		53			-				53
Stock issued as consideration to acquire SAVSU		19,932			-				19,932
Reclassification of warrant liabilities to equity upon exercise	$	-		$	1,695			$	1,695